Investigation of cardiorenal outcomes and incidence of genitourinary tract infection after combined SGLT2 inhibitor and ACEI/ARB use in patients with chronic kidney disease stages 3-5: A real-world retrospective cohort study in Taiwan.
慢性腎病第3-5期患者使用聯合 SGLT2 抑制劑與 ACEI/ARB 後心腎結果及泌尿道感染發生率的調查:台灣的一項真實世界回顧性隊列研究。
Int J Med Sci 2024-09-06
The Incidence and Risk Factors of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Using SGLT2 Inhibitors: A Real-World Observational Study.
2型糖尿病患者使用SGLT2抑制劑尿路感染的發生率和危險因素:一項真實世界觀察性研究。
Medicines (Basel) 2022-12-27
Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study.
腎臟疾病和2型糖尿病患者使用鈉葡萄糖共同轉運蛋白2抑製劑的安全性:美國人口基礎的世代研究。
Clin J Am Soc Nephrol 2024-05-02
Sodium-glucose co-transporter-2 inhibitors are associated with kidney benefits at all degrees of albuminuria: A retrospective cohort study of adults with diabetes.
葡萄糖鈉共同轉運蛋白2抑制劑與腎臟益處相關聯:對糖尿病成年人進行的一項回顧性cohort研究。
Diabetes Obes Metab 2024-01-11
Renal outcomes with sodium-glucose cotransporter 2 inhibitors in Japanese people with grade 3 chronic kidney disease and type 2 diabetes: Analysis of medical administrative databases.
日本患有3級慢性腎臟病和2型糖尿病的人群中,藉由鈉-葡萄糖共同轉運蛋白2抑制劑進行腎臟結果的分析:醫療行政數據分析。
Diabetes Obes Metab 2024-04-09
Risk of CKD among patients with DM taking diuretics or SGLT2i: a retrospective cohort study in Taiwan.
糖尿病患者使用利尿劑或SGLT2抑制劑的腎病風險:台灣的回顧性世代研究。
BMC Pharmacol Toxicol 2024-03-07
The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study.
醫院出院後使用鈉葡萄糖共同轉運蛋白-2抑制劑與二肽基胜肽酶-4抑制劑對2型糖尿病患者腎臟結果的關聯性:一項基於人群的cohort研究。
J Diabetes 2024-04-13
Risk of Urogenital Bacterial Infection with Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study Using a Claims Database.
使用索引資料庫進行的回顧性世代研究:與鈉葡萄糖共同轉運蛋白-2抑制劑相關的泌尿生殖系細菌感染風險。
Diabetes Ther 2024-07-03
Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes.
SGLT2 抑制劑與 GLP-1 受體激動劑在 2 型糖尿病中的腎臟與心血管效果比較。
J Am Coll Cardiol 2024-08-14
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care.
接受常規護理的2型糖尿病患者中,使用SGLT2抑制劑或GLP-1受體激動劑的匹配隊列比較腎臟結果。
Diabetologia 2024-08-23
Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease.
鈉-葡萄糖共轉運蛋白 2 抑制劑對糖尿病及晚期慢性腎病患者心血管和腎臟結果的影響。
Diabetologia 2024-08-29